Publications by authors named "Zoran Filipovic"

Claim this Profile
C
Clinical Significance of Nephrogenic Adenoma of the Urinary Bladder: Implications for Differential Diagnosis and Potential for Malignant Transformation.
Zoran Filipovic, Uros Kojic, Nikola Lukac, Uros Nesic, Djordje Milic

Cureus· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timely Surgical Resection Achieved Prolonged Remission in Patients With Malignant Mesothelioma of the Tunica Vaginalis Testis and Retroperitoneal Recurrence.
Milan Radovanovic, Uros Kojic, Aleksa Zubelic, Djordje Jakulic, Zoran Filipovic

Cureus· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer: The VIABLE Phase 3 Randomized Clinical Trial.
Nicholas J Vogelzang, Tomasz M Beer, Winald Gerritsen, Stéphane Oudard, Pawel Wiechno, Zoran Filipovic

JAMA Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AC105 Increases Extracellular Magnesium Delivery and Reduces Excitotoxic Glutamate Exposure within Injured Spinal Cords in Rats.
Zhihong Huang, Zoran Filipovic, Nandakumar Mp, Chia Ung, Erika L Troy

J Neurotrauma· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent and selective spiroindolinone MDM2 inhibitor, RO8994, for cancer therapy.
Zhuming Zhang, Qingjie Ding, Jin-Jun Liu, Jing Zhang, Nan Jiang, Zoran M Filipovic

Bioorg Med Chem· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical optimization of MDM2 antagonist scheduling for cancer treatment by using a model-based approach.
Brian Higgins, Kelli Glenn, Antje Walz, Christian Tovar, Zoran Filipovic

Clin Cancer Res· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Potent and Orally Active p53-MDM2 Inhibitors RO5353 and RO2468 for Potential Clinical Development.
Zhuming Zhang, Xin-Jie Chu, Jin-Jun Liu, Qingjie Ding, Jing Zhang, Zoran M Filipovic

ACS Med Chem Lett· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stapled α-helical peptide drug development: a potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapy.
Yong S Chang, Bradford Graves, Vincent Guerlavais, Christian Tovar, Kathryn Packman, Zoran Filipovic

Proc Natl Acad Sci U S A· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development.
Qingjie Ding, Zhuming Zhang, Jin-Jun Liu, Nan Jiang, Jing Zhang, Zoran M Filipovic

J Med Chem· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDM2 small-molecule antagonist RG7112 activates p53 signaling and regresses human tumors in preclinical cancer models.
Christian Tovar, Bradford Graves, Kathryn Packman, Zoran Filipovic, Brian Higgins

Cancer Res· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.
Christian Tovar, James Rosinski, Zoran Filipovic, Brian Higgins, Kenneth Kolinsky

Proc Natl Acad Sci U S A· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.
Lyubomir T Vassilev, Binh T Vu, Bradford Graves, Daisy Carvajal, Frank Podlaski, Zoran Filipovic

Science· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrophage inhibitory cytokine-1: a novel biomarker for p53 pathway activation.
Hong Yang, Zoran Filipovic, David Brown, Samuel N Breit, Lyubomir T Vassilev

Mol Cancer Ther· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Short-term cardiovascular effects of plasmapheresis in norepinephrine-refractory septic shock.
Karin Ataman, Michaela Jehmlich, Sabine Kock, Sabine Neumann, Matthias Leischik, Zoran Filipovic

Intensive Care Med· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis